Innovation and Product Development news

• 

  22 May 2026

  Port of Rotterdam demonstrates safe ship-to-ship ammonia bunkering (MAGPIE)

  Full-scale ship-to-ship ammonia bunkering demo found bunkering can be done safely in active ports if planned with robust safety, equipment and regulatory frameworks; report gives practical guidance.
• 

  21 May 2026

  Rely wins Power2X EPC for 20MW Djewels green hydrogen plant in Delfzijl

  Project reached FID/NTP and moves into construction. Will use John Cockerill pressurized alkaline electrolysis; first hydrogen expected mid‑2028; plant ties into local Chemical Park and Nobian.
• 

  21 May 2026

  PureCycle and Reliable Caps launch closures made with PureFive recycled polypropylene (up to 75% PCR)

  Bright white, colorable closures using certified, domestically sourced recycled PP; FDA-grade and GreenCircle‑certified, suited for contact‑sensitive food, beverage and personal‑care packaging.
• 

  21 May 2026

  Hycamite plans 200 kt/yr graphite plant in Finland

  EU CRMA status and new tech enable a phased Finnish project: Phase 1 demo starts next year; full scale could reach 200 kt/yr (~40% of EU battery graphite demand), serving batteries and industry.
• 

  21 May 2026

  Lilly’s retatrutide achieves up to 30% weight loss in Phase 3 TRIUMPH-1

  Phase 3 TRIUMPH-1: three doses met endpoints at 80 weeks with dose-related, substantial weight loss. 104-week extension in BMI≥35 showed further loss; cardiometabolic markers improved; GI AEs common.
• 

  21 May 2026

  ADNOC deploys Taurob heavy‑duty inspection robot and co‑develops operator robot

  Inspector robot conducts autonomous hazardous-site inspections with LiDAR and thermal imaging. A heavy-duty operator robot to lift, grip and turn valves in extreme temperatures — operational 2026.

• 

  21 May 2026

  Croda launches Beauty of Zero for zero‑impact beauty

  New programme targets zero‑impact beauty across six pillars (NetZero, Waste, Biodiversity, Water, Exploitation, Ambiguity) using biotech ingredients, renewable sourcing, LCA metrics & circularity.
• 

  21 May 2026

  EemsGas secures €149.8m SDE++ operating subsidy for biomethane production

  Project (>€100m) will build a demolition-wood gasification plant producing 18M m3/yr biomethane. Earlier €30m DEI+ grant. Construction 2027, operation 2029. Subsidy secures 15‑yr revenue
• 

  21 May 2026

  Asahi Kasei develops PSPI film for panel-level semiconductor packaging

  New photosensitive polyimide film combines liquid PSPI and dry-film photoresist for uniform lamination on large panels, enabling finer circuits, extra insulating layers and higher yields.
• 

  21 May 2026

  Shofu, Tosoh, Mitsui Chemicals, Orbray launch zirconia dental-waste recycling project

  Verification project to recycle zirconia dental milling waste into regenerated raw material and remanufactured blocks for reuse; practical use targeted by FY2028 with dental labs.
• 

  21 May 2026

  Kemira and CuspAI design AI‑generated PFAS‑removal materials

  Generative AI designed novel MOFs targeting PFAS (GenX, PFBS, PFOS), screened ~300T structures, yielded 5,000 candidates narrowed to ~20 in six months; next phase: development and testing
• 

  20 May 2026

  BASF Coatings named GM 2025 Supplier of the Year

  Named 2025 Supplier of the Year at a 34th annual Austin event for outstanding performance, innovation and partnership; one of 103 global awardees; readies for Carlyle ownership transition in Q2 2026.
• 

  20 May 2026

  Covestro opens TPU Application Development Center in Guangzhou, China

  New TPU AD Center links Zhuhai production and Changhua R&D, offering extrusion/injection simulation, compounding, color and pilot film lines to speed APAC solutions
• 

  20 May 2026

  BASF and Cromology convert end‑of‑life tires into binder for Tollens Maxiline+ wall paint

  Chemically recycled styrene-acrylate binder from tire pyrolysis oil used in interior wall paint via mass-balance. REDcert² certified; 10 L ≈ 2 tires; reduces fossil feedstock and CO₂.
• 

  20 May 2026

  Lindex and BASF introduce loopamid recycled polyamide for lingerie

  A recycled polyamide 6 made from textile waste can recycle blended fabrics, match virgin quality for multiple cycles; lingerie items using it are planned for early 2027.
• 

  20 May 2026

  BASF patents hot-gas welding process for PPA plastics

  Channel-guided hot-gas welding yields uniform heating, ~10s welds, lower temperatures and energy use, thicker melt layers, fewer clogs and higher reliability for thermoplastic components.
• 

  19 May 2026

  European Commission unveils Fertiliser Action Plan to secure EU fertiliser supply and food security

  Immediate liquidity relief and CAP flexibility for farmers; boost domestic, low‑carbon and circular production; improve market transparency, monitoring, and preparedness.
• 

  19 May 2026

  WACKER launches CRS for nucleic-acid medicines

  CRS offers R&D-grade pDNA, RNA and LNP production, construct design, lipid screening and analytical services for preclinical studies, with seamless scale-up to GMP clinical supply.
• 

  19 May 2026

  Novo Nordisk: Semaglutide shows hepatic safety and efficacy in MASH

  ESSENCE subgroup analyses (menopause, Japanese) and real-world data show broad benefit across populations, highlight severe underdiagnosis, reduced quality of life and rising healthcare costs
• 

  18 May 2026

  Boehringer Ingelheim's JASCAYD (nerandomilast) approved in Japan for IPF and PPF

  First oral PDE4B inhibitor shows slowed FVC decline in FIBRONEER Phase III; pooled analysis showed 59% nominal death reduction. Common AE: diarrhea; EU/UK reviews ongoing.
• 

  18 May 2026

  Asahi Kasei Starts Phase III Trial of Teribone for High‑Risk Osteoporosis

  Phase III in Japan will evaluate extended teriparatide acetate treatment beyond 24 months for severe osteoporosis patients at high fracture risk, assessing efficacy and safety of continued dosing.
• 

  18 May 2026

  Dow launches Coolant Care Network for data center liquid cooling

  End-to-end coolant management for data centers: approved labs and service providers, centralized data review, expert analysis and field support to improve uptime and cut operational risk.
• 

  18 May 2026

  Genentech to present ASCO 2026 data on giredestrant in early ER+ breast cancer

  Presents data on nine drugs across 15+ indications: breast‑cancer first‑line/post‑progression analyses, HER2 brain‑penetrant TKI, KRAS G12C+pembrolizumab, and lymphoma ADC/bispecific combo
• 

  18 May 2026

  NRC Issues FONSI for Dow and X-energy Long Mott Nuclear Project in Texas

  NRC completed an Environmental Assessment and issued a FONSI for a proposed advanced SMR at Seadrift, Texas, clearing a key Construction Permit step to supply electricity and industrial steam.
• 

  18 May 2026

  Aramco and Pasqal launch Saudi Arabia’s first quantum computer and the Middle East’s first QCaaS platform

  Located in Dhahran, a 200-qubit neutral-atom QPU offers low-latency cloud access for industrial apps, enabling optimization, simulation and AI for energy, materials, logistics, CO2 storage; workforce training.
• 

  18 May 2026

  BASF opens refinery catalyst R&D center in Attapulgus, GA

  R&D center focuses on applied FCC testing, QA/QC and scale-up at production site to speed commercialization and tailor catalyst solutions to refiners
• 

  18 May 2026

  Merck: sac‑TMT meets OS and PFS endpoints in Phase 3 TroFuse‑005 for advanced/recurrent endometrial cancer

  TroFuse‑005 (776 pts) showed significant OS and PFS improvement vs chemotherapy in advanced/recurrent endometrial cancer after platinum and anti‑PD‑1/PD‑L1 therapy; ORR met; safety consistent.
• 

  18 May 2026

  Asahi Kasei Therapeutics starts Phase III trial of Teribone (teriparatide) for high‑risk osteoporosis

  Domestic Phase III trial to assess extended therapy beyond 24 months for patients with severe osteoporosis at high fracture risk; evaluates efficacy and safety of continued treatment.
• 

  18 May 2026

  Chugai’s Alecensa Gets World-First Tumor‑Agnostic Approval for ALK‑Positive Solid Tumors

  Japan approves tumor‑agnostic ALK inhibitor for ALK‑fusion solid tumors including pediatrics. TACKLE Phase II showed 70–76% response in ALK‑fusion cases; safety consistent. FoundationOne CDx approved.
• 

  15 May 2026

  Genentech’s Tecentriq approved by FDA as ctDNA‑guided adjuvant therapy for MIBC

  FDA approves first ctDNA‑MRD‑guided adjuvant option for muscle‑invasive bladder cancer. IMvigor011: ctDNA+ patients had 36% reduced DFS risk and 41% reduced OS risk; Signatera CDx authorized.